ProPhase Labs (PRPH) Scheduled to Post Quarterly Earnings on Wednesday

ProPhase Labs (NASDAQ:PRPH) will be announcing its earnings results before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

ProPhase Labs (NASDAQ:PRPH) last announced its earnings results on Wednesday, August 14th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.25). The business had revenue of $2.47 million for the quarter. ProPhase Labs had a negative return on equity of 54.04% and a negative net margin of 146.39%. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ProPhase Labs Stock Performance

Shares of PRPH stock opened at $0.74 on Tuesday. The stock has a market cap of $14.10 million, a P/E ratio of -0.61 and a beta of -0.10. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.58 and a quick ratio of 1.44. The company has a fifty day moving average price of $2.31 and a two-hundred day moving average price of $3.35. ProPhase Labs has a one year low of $0.66 and a one year high of $7.48.

About ProPhase Labs

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.